Enteroviruses
Types
Cocksackie
A
B
Echo
Polio
Other
Polio
Characteristics
Pathophysiology
Clinical
Post-polio syndrome
30-40 years after acute
Symptoms
ALS-like
Non life-threatening
Paralytic polio
Fever
Malaise
Head ache
Stiff neck
Meningitis-like symptoms
Infantile paralysis (possible)
Diagnosis
Tissue culture
Serology
PCR
Kits
Epidemiology
Paradox
Children w/ poor hygiene & sanitation
Improved sanitation correlated with increased epidemics
Exposure postponed to older children, adults
Disease more severe
Incubation period
2-10 days
99% asymptomatic
1% paralysis, death from resp. failure
Prevention
Vaccines
Killed Salk
No viral replication
Safe for immunodeficient
Induces humoral immunity
Live Sabin
Confers intestinal immunity (IgM)
Economical, stable, administered in field
Spread to other house members
Poliomyelitis
Treatment
Post-polio
No specific AV
General
Characteristics
Structure
Molecular
VP1-4 capsid proteins
VPg protein
5' end
Viral encoded RNA polymerase
Infectious mRNA to polyprotein P1
Small
Icosahedral
Infection time course
General properties
GI tract
Grow at 37 degrees
Shed in feces
Cultured in primates
67 serotypes
Resistant
Low pH
Common disinfectants
Sensitive
Hypochlorite
Formaldehyde
Clinical
Cocksacievirus B
CNS
Viral meningitis
Encephalitis
Cardio
Myocarditis
Pericarditis
Pleurodynia
Polio-like paralysis
Pancreatic (diabetes) and resp. infections
Cocksackievirus A
Hand-foot-and-mouth disease
Cold-like symptoms
Blister-like rash on hands, feet
Self-limiting
Herpangina
Enterovirus 72
Hepatitis A disease
Echovirus, Coxsackie A21 or A24
Rhinovirus-like "colds"
Poliovirus
Polio
Post-polio syndrome
Epidemiology
Transmission
Fecal-oral
Human host needed
Place
Widespread
DCC
Person
Common in children
Time
Temperate
Summer, autumn
Tropical
Year-round
Treatment
Coxsackievirus infection
Self-limiting
Pleconaril
Not FDA-approved
Blocks uncoating step